NK Cells in Cancer Immunotherapy: Successes and Challenges

NK Cells in Cancer Immunotherapy: Successes and Challenges is a valuable resource for cancer researchers, oncologists, graduate students, and those interested in learning more about novel strategies to treat cancer patients.

Format: Hardback
Length: 350 pages
Publication date: 01 December 2022
Publisher: Elsevier Science Publishing Co Inc

NK Cells in Cancer Immunotherapy: Successes and Challenges is a comprehensive guide that delves into the latest immunotherapeutic strategies, with a particular focus on NK cells. By understanding the role of NK cells in cancer immunotherapy, the book aims to enable the development of the most effective and precise combination treatments for cancer patients. The book provides a comprehensive overview of the field of immunotherapy, covering existing background knowledge and discussing the future areas of research required to carry out cutting-edge, validated therapies.

Chapters in the book explore advances in immunotherapeutic strategies, particularly the use of NK cells with and without T-cell therapy in the treatment of cancer. The authors highlight the potential benefits of NK cells in targeting and eliminating cancer cells, as well as their ability to stimulate the immune system to mount a robust response against cancer.

NK Cells in Cancer Immunotherapy: Successes and Challenges is a valuable resource for cancer researchers, oncologists, graduate students, and individuals interested in learning more about novel strategies to treat cancer patients. The book offers a comprehensive and up-to-date perspective on NK cells in cancer immunotherapy, providing insights into the latest research, clinical trials, and treatment approaches.

While immunotherapy has shown promising results in treating cancer, there are still significant challenges to overcome. One of the main challenges is the development of long-lasting treatment strategies that effectively target and eliminate cancer cells. Many of the current immunotherapeutic strategies, such as checkpoint inhibitors, do not provide durable treatment outcomes, and patients often experience relapse or resistance to these treatments.

Another challenge is the identification of appropriate patient populations that are most likely to benefit from immunotherapy. Different types of cancer may respond differently to immunotherapeutic treatments, and there is a need for more personalized approaches that take into account the genetic makeup, tumor microenvironment, and other factors that can influence treatment response.

To address these challenges, researchers are actively exploring new immunotherapeutic strategies, including the use of combination therapies, targeted therapies, and immunomodulators. They are also working to improve our understanding of the immune system and its role in cancer development and progression, which can lead to the development of more effective and personalized treatment approaches.

In conclusion, NK Cells in Cancer Immunotherapy: Successes and Challenges is a valuable resource for anyone interested in learning more about the latest immunotherapeutic strategies and their potential for treating cancer. The book provides a comprehensive overview of the field, covering advances in NK cell therapy, T-cell therapy, and combination therapies. By understanding the role of NK cells in cancer immunotherapy, researchers and healthcare professionals can work towards developing more effective and personalized treatment approaches that improve the outcomes for cancer patients.

Dimension: 235 x 191 (mm)
ISBN-13: 9780128226209